Neurologists, Primary care providers, Emergency medicine providers, Nurse practitioners, Physician assistants, Nurses
Wade Cooper, DO
Director, Headache and Neuropathic Pain
Clinical Associate Professor, Neurology and Anesthesiology
University of Michigan
Ann Arbor, Michigan
Dr. Wade Cooper is the Director of Headache and Neuropathic Pain at the University of Michigan where he is also a Clinical Associate Professor in Neurology and Anesthesiology. Dr. Cooper graduated from Michigan State University’s College of Osteopathic Medicine where he obtained his medical degree in 2000. He completed his residency in neurology at Michigan State University in East Lansing, Michigan, in 2004. He also completed a fellowship in headache medicine at the Michigan Head Pain and Neurological Institute in 2005. Dr. Cooper holds a United Council for Neurologic Subspecialties (UCNS) board certification in headache medicine.
Dr. Cooper has published numerous articles and medical textbook chapters. He serves on the Editorial Board for Headache, the official journal of the American Headache Society.
Provided by Albert Einstein College of Medicine-Montefiore Medical Center
Joint Accreditation Statement
In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Credit Designation Statement
Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Albert Einstein College of Medicine-Montefiore Medical Center requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. The Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States. All identified COI are thoroughly vetted and resolved according to Albert Einstein College of Medicine-Montefiore Medical Center policy. Albert Einstein College of Medicine-Montefiore Medical Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
David M. Kaufman, MD
Professor of Neurology and Psychiatry
Albert Einstein College of Medicine
Montefiore Medical Center
David Kaufman, MD has no relevant conflicts of interest to report.
The planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Wendy Gloffke, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Anne Roc, PhD, has no relevant conflicts of interest to report.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Wade Cooper, DO, has disclosed that he has received consulting fees from Alder, Allergan, Amgen, Lilly, and Teva and fees for non-CME/CE services from Amgen and Lilly.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Commercial Support Statement:This activity is supported by educational funding provided by Amgen.
COURSE VIEWING REQUIREMENTS